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There Are Many Different Ways to Skin a Cat . . . 
Of the many inflammatory diseases of the skin, psoriasis is clearly 
one of the most intriguing and complex. Indeed, psoriasis is a family 
of diseases sharing similar clinical and histopathologic findings, but 
dla:ering greatly in extent, pace, and heredity. There is a clear ge-
netic susceptibility in a number of forms of psoriasis, but what is the 
target of genetic control- epidermal cytokine release or response, 
vascular reactivity, or lymphocyte activation? It is generally ac-
cepted that blood vessels are an early site of response in developing 
psoriasis, that epidermal hyperproliferation is a basic feature, that 
lymphocyte activation is a central feature, and that activation of 
granulocytes and perhaps basophil and mast cells are components of 
the developing inflammatory responses. In this issue are three arti-
cles with very different approaches to the measurement of inflam-
matIOn and epidermal function in psoriasis. 
Wanda Schroeder and her colleagues at The University of Texas 
at Houston, the M.D . Anderson Cancer Center, and Texas A&M 
University have examined the distribution of type I keratinocyte 
transglutaminase (TGase) in normal and psoriatic skin. This en-
zyme is involved in the formation of the cornified envelope, a fea-
ture of terminally differentiating keratinocytes. Using quantitative 
laser scanning confocal microscopy and in situ hybridization, they 
found that the levels of TGase mRN A were 3 - 7 times higher in 
psoriatic epidermis than in normal epidermis. They also demon-
strated precocious expression of the TGase protein in psoriatic epi-
dermiS. The techniques that they describe provide powerful direct 
methods for quantitation of gene expression in skin, and again dem-
O~strate that psoriatic epidermis shows consistent abnormalities in 
differentiation. This indicates strong local stimuli for proliferation, 
and suggests that genetic abnormalities in response to such stimuli 
may determine the development of the psoriatic epidermal pheno-
type. 
This article demonstrates the utility of techniques of molecular 
biology applied directly to the study of the epidermis in psoriasis. 
The next two articles use nearly the opposite approach, studying the 
urine of psoriatic patients for the production of products associated 
with presumed cutaneous events in psoriasis. In the first paper, Hans 
Alkemade and colleagues from the Academic Hospital Nijmegen in 
The Netherlands measured the presence of a new elastase inhibitor 
(skin-derived antileukoproteinase, SKALP) in the urine of psoriatic 
patients. It is believed that this antiproteinase derived from the 
epidermis may be necessary to oppose the function of leukocyte 
proteinases produced during inflammation. This proteinase is indu-
cible in normal skin by tape stripping and may be a regulatory 
mechanism to protect against elastase-induced tissue damage. The 
identification of very high levels of this anti-proteinase in the urine 
of psoriatic patients provides further substantiation that the epider-
mis in psoriasis is activated to deal with leukocyte-induced inflam-
matory events. 
The final paper on psoriasis in this group is by Joachim Fauler and 
others from Hannover Medical School in Hannover, Germany. 
These investigators examined the urine of psoriatic patients for the 
presence of cysteinylleukotrienes, specifically L TE4 , the major me-
tabolite ofLTC4 and LTD4. These two leukotrienes, produced by 
eosinophils, basophils, and mast cells, are potent pro-inflammatory 
mediators that affect microvascular tone and permeability. The au-
thors identified very high levels of the metabolite of these two 
leukotrienes in the urine of psoriatic patients, strongly implicating 
mast-cell- mediated release as a major step in the pathogenesis of 
psoriasis. These findings complement other work identifying L TB4 
as a major inflammatory mediator in psoriasis involved directly or 
indirectly in the mobilization of neutrophil microabcesses. The 
complexities of the pathogenesis of psoriasis are increasingly sub-
stantiated by detailed investigation of discreet aspects of the biology 
of the epidermis, blood vessels, and inflammatoty cells in psoriasis. 
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Further Characterization of Primary Localized Cutaneous Amyloidosis 
Primary cutaneous amyloidosis includes lichen amyloidosis (LA), 
macular amyloidosis (MA), and nodular amyloidosis (NA). In NA 
the amyloid fibril protein is highly homologous with, and is appar-
ently derived from, the immunoglobulin light chain. In LA and MA 
it is assumed that the fibrillar protein originates in keratinocytes . 
There are two basic theories on the origi':l of this amyloid in LA and 
MA. The fibrillar body theory holds that amyloid results from fibril-
lar degeneration of epidermal cells and modification of kertinocyte 
fibrils that "drop off" into the dermis. The secretion theory holds 
that the precursor of amyloid protein is secreted by basal keratino-
cytes and leads to the formation of amyloid fibrils at the epidermal/ 
dermal interface. 
In this issue, Yuji Horiguchi and co-workers at Kyoto University 
in Kyoto, Japan, and at the University of North Carolina in the 
USA demonstrate abnormalities in the structure of the lamina densa 
of the basement membrane overlying amyloid deposits. They also 
show that numerous components of the basement membrane, in-
cluding laminin and types IV and VII collagen, were closely asso-
ciated with the fibrillar amyloid deposits. The authors feel that their 
findings support the secretion theory of the amyloid generation, and 
note that they found no differences between LA and MA, in distinc-
tion to other investigators. These findings will not resolve the issue 
of the mechanism of amyloid formation in LA and MA. However, 
they provide further evidence that amyloid deposits are complex 
protein aggregates composed of multiple keratinocyte-derived pro-
teins. 
Another Genodermatosis Associated with a Primary Keratin Defect? 
One of the most exciting successes of molecular genetics is the 
recent description of point mutations in the basal cell keratins K5 
and K14 and kindreds with epidermolysis bullosa simplex. As re-
cently reviewed by Ervin Epstein (Science 256:799 - 804, 1992), 
this research is an important step in understanding the fundamental 
role of intermediate filaments, as exemplified by the keratin fila-
ments of keratinocytes. These results were preceded by ultrastruc-
tural investigation that suggested that basal cell keratins, or other 
cytoskeletal molecules, might be candidates for mutations produc-
ing abnormal keratin filaments, leading to epidermal separation in 
simplex variants of EB. 
In this issue of the Journal, Akemi Ishida-Yamamoto and col-
leagues in London and Dundee provide morphologic evidence that 
the cytoskeletal abnormality in epidermolytic hyperkeratosis (bul-
lous congenital ichthyosiform erythroderma) resides in keratins K1 
and/ or K1 O. In skin samples of patients, tonofilament abnormalities 
were demonstrated in suprabasal keratinocytes in the epidermis, in 
the infundibular region of outer root sheaths, and in the sebaceous 
ducts and sweat ducts, following the known distribution of keratins 
K 1 and K 10. The abnormal findings were not seen in other epithelia 
or in cultured keratinocytes where keratins K1 and K10 were absent 
or minimally expressed. Immunoelectron microscopy also showed 
localization of the tonofilament defect to K1 and K10. These results 
will help direct molecular biologists to identify the molecular basis 
for epidermolytic hyperkeratosis, and will substantiate the impor-
tance of any identified mutation in these genes. The combination of 
traditional ultrastructural approaches with modern techniques in 
molecular biology demonstrates the elegance and potential power 
of modern research. 
